David B. Roberts - 11 Mar 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: President and Director, Director
Issuer ticker: LMAT
Reported as of: 11 Mar 2026
Net transaction value: -$356,586
SEC form: 4
Accepted by SEC: 13 Mar 2026, 16:42:12 UTC
Prior SEC filing: 02 Mar 2026
Next SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

David B. Roberts filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 13 Mar 2026.

Key facts

This page summarizes David B. Roberts's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Mar 2026, 16:42.

Change

Previous filing in this sequence was filed on 02 Mar 2026.
Current net transaction value: -$356,586.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001365731 Primary reporting owner

Roberts David B

Relationship: President and Director, Director
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Signature date: 13 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMAT transaction

Common Stock

Sale

Transaction value: $356,586
Shares: -3,312
Change %: -18%
Price: $107.68
Shares after: 14,667
Date: 11 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.52 to $108.65. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.